You might want to have another look at the announcement "Botanix Joins with UQ to Accelerate Development of BTX 1801". It doesn't read as if the study is independent of BOT. And the research grant, from what I've found is a maximum of 50 grand. BOT and/or UQ have to be injecting money into this study. Does anyone know what "deal" could have been struck between BOT and UQ?
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-123
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $1.169M | 3.655M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 274982 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 48600 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
